Qi-jiong Li
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Lenvatinib, toripalimab plus hepatic arterial infusion chemotherapy in patients with high-risk advanced hepatocellular carcinoma: A biomolecular exploratory, phase II trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 05, 2022
Reply to J. Mei et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 22, 2022
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma.
Journal: Technology in cancer research & treatment
Published: December 13, 2021
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 14, 2021
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: December 22, 2020
Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma.
Journal: Frontiers in oncology
Published: October 20, 2020
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma.
Journal: Therapeutic advances in medical oncology
Published: September 28, 2020
Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.
Journal: Cancer immunology, immunotherapy : CII
Published: July 16, 2020
NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma.
Journal: Cancer cell international
Published: June 05, 2019
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.
Journal: Cancer communications (London, England)
Published: April 09, 2019
Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study.
Journal: Nutrition & metabolism
Published: September 18, 2018
Last Updated: 09/26/2026